Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/27270872
Conclusion of this study
There were also significant reductions in body mass index and serum levels of total cholesterol, low-density lipoprotein cholesterol, triglycerides, aspartate aminotransferase, alanine aminotransferase, glucose, and glycated hemoglobin compared with the placebo group. Curcumin was safe and well tolerated during the course of trial. Findings of the present proof-of-concept trial suggested improvement of different features of NAFLD after a short-term supplementation with curcumin.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study